News

SGLT2 inhibitors reduce hyperkalemia risk, aiding RAASi continuity in high-risk patients.

The study concludes that ED-based opt-out testing is both effective and acceptable in detecting hepatitis.

A new study has revealed a potential link between live zoster vaccination and a reduced risk of cardiovascular disease.

Read how a recent study showed widespread cardiopulmonary abnormalities in long COVID patients one year post-infection.

Baseline brain circuit activity predicts who benefits most from MDMA, paving the way for personalised psychiatric treatments.

A recent study has found that women with sickle cell disease experience higher inflammation during the follicular phase of their menstrual cycle, which may explain the timing of pain episodes and offer insight into more personalised care.

Semaglutide significantly improves liver inflammation and fibrosis in MASH patients, offering new hope for clinical management.

The study concludes that decentralised and person-centred hepatitis screening is effective and essential.

A new study sheds light on the role of CD4 T cell autophagy, a cellular recycling process, in the progression of liver fibrosis.

Researchers from the OsteoLaus cohort have developed a machine learning model to predict fragility fractures in postmenopausal women using bone and body composition data.

Clinically, this discovery could reshape the understanding of immune regulation in ulcerative colitis.

Restoring the skin barrier is key in managing and potentially preventing atopic dermatitis.

A retrospective analysis of global data has found that a specific treatment sequence, starting with small molecule inhibitors and followed by epigenetic modifiers, may significantly improve survival in patients with relapsed or refractory T-cell lymphomas.

Read about how mirikizumab shows strong results for IBD, improving remission and response rates.

Early results support the theory that combining systemic and localised treatment in oligometastatic prostate cancer can improve tumour control.

Discover how HSK31858 could transform bronchiectasis treatment by reducing flare-ups – read more about the latest trial results.

Understand how ultrasound-guided PDT improves first-puncture success and reduces bleeding risk compared to landmark guidance.

Find out how maternal hypertension affects preterm infant brain development and why early intervention is crucial – read more.

Low-energy diets are safe in pregnancy with gestational diabetes but show no clinical benefit in weight or birth weight.

Researchers developed a new evolutionary framework centred on immune robustness, the ability to fight infection while limiting damage.

A large cohort study has found that chemoradiotherapy offers no survival advantage over radiotherapy alone in intermediate-risk cervical cancer patients—raising questions about current treatment practices.

This research highlights the importance of innovative blood-based diagnostics in bridging current gaps.

Results from the phase 3 QUASAR trials show that guselkumab offers effective and safe induction and maintenance therapy for moderate-to-severe ulcerative colitis, with nearly 50% of patients achieving clinical remission after one year.

A revolutionary test saved a young doctor’s eyesight by uncovering a rare infection after years of unanswered questions.